Pulmonary artery sealing with ultrasonic energy in open lobectomy: A phase I clinical trial

被引:14
|
作者
Goudie, Eric [1 ]
Thiffault, Vicky [1 ]
Jouquan, Adeline [1 ]
Lafontaine, Edwin [1 ]
Ferraro, Pasquale [1 ]
Liberman, Moishe [1 ]
机构
[1] Univ Montreal, Endoscop Tracheobronchial & Oesophageal Ctr, Endoscop Tracheobronchial & Oesophageal Ctr CETOC, CHU Montreal,Dept Surg,Div Thorac Surg, Montreal, PQ, Canada
来源
关键词
pulmonary artery sealing; energy; VATS lobectomy; ultrasonic energy; THORACOSCOPIC LOBECTOMY; LUNG-CANCER; SURGERY LOBECTOMY; VASCULAR LIGATION; THORACIC-SURGERY; STAGE-I; RESECTION; DEVICES; COMPLICATIONS; THORACOTOMY;
D O I
10.1016/j.jtcvs.2016.12.049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Pulmonary artery branch sealing in video-assisted thoracoscopic surgical lobectomy is usually achieved with vascular endostaplers. Iatrogenic pulmonary artery injury may be caused by endostaplers. We evaluated the safety of pulmonary artery sealing with an ultrasonic energy vessel-sealing device in a phase I clinical trial evaluating in vivo safety of the device during open lobectomy. Methods: Patients scheduled to undergo elective open (thoracotomy) pulmonary lobectomy were prospectively enrolled. Target sample size was 10 patients. Pulmonary artery diameter was measured intraoperatively. All branches <= 7mmwere divided with an ultrasonic energy vessel-sealing device. The remainder of the lobectomy was performed in a standard fashion. Intraoperative and postoperative bleeding were strictly recorded. Results: Eighteen patients were prospectively enrolled. Eight patients were not amenable to pulmonary artery sealing with the device. In the 10 patients included in the analysis, a total of 14 pulmonary arteries were sealed with the ultrasonic device. The mean vessel diameter was 5 mm (range, 2-7 mm). One patient underwent reoperation for bronchial artery bleeding (vessel not sealed with device). There was no intra-or postoperative bleeding related to ultrasonic pulmonary artery sealing. There was no postoperative mortality. Conclusions: Pulmonary artery sealing for vessels with diameter <= 7 mm was safely achieved with an ultrasonic energy vessel-sealing device in open lobectomy. The use of ultrasonic energy vessel-sealing devices in video-assisted thoracoscopic surgical lobectomy may have the advantage of making small, short, pulmonary artery branch sealing safer than with vascular endostaplers. Further studies are necessary before widespread application in lobectomy, including video-assisted thoracoscopic surgical lobectomy.
引用
收藏
页码:1600 / 1606
页数:7
相关论文
共 50 条
  • [1] Phase 1 Trial Evaluating Safety of Pulmonary Artery Sealing With Ultrasonic Energy in VATS Lobectomy
    Goudie, Eric
    Oliveira, Ricardo L.
    Thiffault, Vicky
    Jouquan, Adeline
    Lafontaine, Edwin
    Ferraro, Pasquale
    Liberman, Moishe
    ANNALS OF THORACIC SURGERY, 2018, 105 (01): : 214 - 220
  • [2] Prospective, multicenter, international phase 2 trial evaluating ultrasonic energy for pulmonary artery branch sealing in video-assisted thoracoscopic surgery lobectomy
    Liberman, Moishe
    Goudie, Eric
    Morse, Christopher
    Hanna, Wael
    Evans, Nathaniel
    Yasufuku, Kazuhiro
    Sampalis, John
    Malthaner, R.
    Dunning, J.
    Lafontaine, E.
    Ferraro, P.
    Wright, C.
    Auchincloss, H.
    Lanuti, M.
    Martin, J.
    Ott, H.
    Gaissert, H.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 159 (01): : 301 - 311
  • [3] Pulmonary Artery Sealing With an Ultrasonic Energy Device in Video-Assisted Thoracoscopic Surgery Lobectomy: An Animal Survival Study
    Goudie, Eric
    Khereba, Mohamed
    Tahiri, Mehdi
    Hegde, Pravachan
    Thiffault, Vicky
    Hadjeres, Rachid
    Berdugo, Jeremie
    Ferraro, Pasquale
    Liberman, Moishe
    ANNALS OF THORACIC SURGERY, 2016, 102 (04): : 1088 - 1094
  • [4] Bronchial or Pulmonary Artery Chemoembolization for Unresectable and Unablatable Lung Metastases: A Phase I Clinical Trial
    Boas, F. Edward
    Kemeny, Nancy E.
    Sofocleous, Constantinos T.
    Yeh, Randy
    Thompson, Vanessa R.
    Hsu, Meier
    Moskowitz, Chaya S.
    Ziv, Etay
    Yarmohammadi, Hooman
    Bendet, Achiude
    Solomon, Stephen B.
    RADIOLOGY, 2021, 301 (02) : 474 - 484
  • [5] Phase-I-Study for Occlusion of the Pulmonary Artery with Ultrasound Energy
    Ruchalla, Elke
    ZENTRALBLATT FUR CHIRURGIE, 2017, 142 : S7 - S7
  • [6] Heat production during pulmonary artery sealing with energy vessel-sealing devices in a swine model
    Goudie, Eric
    Oliveira, Ricardo
    Thiffault, Vicky
    Jouquan, Adeline
    Hadjeres, Rachid
    Berdugo, Jeremie
    Ferraro, Pasquale
    Liberman, Moishe
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2020, 31 (06) : 847 - 852
  • [7] Pulmonary Artery Sealing Using the HARMONIC ACE plus Shears for Video-Assisted Thoracoscopic Surgery Lobectomy
    Liberman, Moishe
    Khereba, Mohamed
    Nasir, Basil
    Goudie, Eric
    Danino, Alain
    Giot, Jean-Philippe
    Nizard, Nathanael
    Hadjeres, Rachid
    Thiffault, Vicky
    Farrenq, Nicolas
    Ferraro, Pasquale
    ANNALS OF THORACIC SURGERY, 2015, 100 (03): : 898 - 904
  • [8] A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis
    Blackwell, Timothy S.
    Hewlett, Justin C.
    Mason, Wendi R.
    Martin, Susan
    Del Greco, James
    Ding, Guixiao
    Wu, Pingsheng
    Lancaster, Lisa H.
    Loyd, James E.
    Dudenhofer, Rosemarie B.
    Salisbury, Margaret L.
    Kropski, Jonathan A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (08) : 1291 - 1297
  • [9] A Phase I Clinical Trial of Targeted Intraoperative Molecular Imaging for Pulmonary Adenocarcinomas
    Predina, Jarrod D.
    Newton, Andrew D.
    Keating, Jane
    Dunbar, Ashley
    Connolly, Courtney
    Baldassari, Michael
    Mizelle, Jack
    Xia, Leilei
    Deshpande, Charuhas
    Kucharczuk, John
    Low, Philip S.
    Singhal, Sunil
    ANNALS OF THORACIC SURGERY, 2018, 105 (03): : 901 - 908
  • [10] Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial
    Skubitz, KM
    Anderson, PM
    ANTI-CANCER DRUGS, 2000, 11 (07) : 555 - 563